Malignant pleural mesothelioma: recent developments

K Sinn, B Mosleh, MA Hoda - Current opinion in oncology, 2021 - journals.lww.com
Malignant pleural mesothelioma: recent developments : Current Opinion in Oncology Malignant
pleural mesothelioma: recent developments : Current Opinion in Oncology Log in or Register …

[HTML][HTML] Emerging treatments for malignant pleural mesothelioma: where are we heading?

L Cantini, R Hassan, DH Sterman, JGJV Aerts - Frontiers in Oncology, 2020 - frontiersin.org
Malignant pleural mesothelioma (MPM) is an uncommon but aggressive and treatment
resistant neoplasm with low survival rates. In the last years we assisted to an exponential …

Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application

P Majumder, A Singh, Z Wang, K Dutta… - Nature …, 2021 - nature.com
Tumours growing in a sheet-like manner on the surface of organs and tissues with complex
topologies represent a difficult-to-treat clinical scenario. Their complete surgical resection is …

Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications

NS Kulkarni, G Chauhan, M Goyal, S Sarvepalli… - Biomaterials …, 2022 - pubs.rsc.org
Applicability of hydrogels as drug delivery systems is on the rise due to their highly tunable
degree of polymeric crosslinking to attain varying rates of payload release. Sustaining the …

[HTML][HTML] The epithelial-to-mesenchymal transition (EMT) in the development and metastasis of malignant pleural mesothelioma

V Ramundo, G Zanirato, E Aldieri - International Journal of Molecular …, 2021 - mdpi.com
Malignant pleural mesothelioma (MPM) is an aggressive tumor mainly associated with
asbestos exposure and is characterized by a very difficult pharmacological approach. One of …

[HTML][HTML] Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo

M Benvenuto, V Angiolini, C Focaccetti, D Nardozi… - Biology Direct, 2023 - Springer
Background Malignant mesothelioma (MM) is a rare tumor with a dismal prognosis. The low
efficacy of current treatment options highlights the urge to identify more effective therapies …

Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases

HL Moberg, I Gramer, I Schofield… - Veterinary and …, 2022 - Wiley Online Library
Canine malignant mesothelioma (CMM) is a rare and aggressive tumour associated with a
poor prognosis. Limited information is available regarding effective treatment options and …

[HTML][HTML] Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results

V Aprile, D Bacchin, S Korasidis… - Annals of …, 2021 - ncbi.nlm.nih.gov
Objective With this narrative review, we retraced the history of hypertermic intrathoracic
chemotherapy (HITHOC) since the beginning, analyzing literature on operative technique …

[HTML][HTML] Hyperthermic intrathoracic chemoperfusion for malignant pleural mesothelioma: Systematic review and meta-analysis

T Järvinen, J Paajanen, I Ilonen, J Räsänen - Cancers, 2021 - mdpi.com
Simple Summary Treatment of malignant mesothelioma with high-temperature
chemotherapeutic instillation of the affected pleural space seems to be advantageous, but …

[HTML][HTML] Hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: the forefront of surgery-based multimodality treatment

V Aprile, A Lenzini, F Lococo, D Bacchin… - Journal of Clinical …, 2021 - mdpi.com
Introduction: Malignant Pleural Mesothelioma (MPM) is characterized by an aggressive
behavior and an inevitably fatal prognosis, whose treatment is still far from being …